VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MCHX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MCHXMarchex, Inc.
$1.79$79M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. MCHX
  4. Financial Ratios

Marchex, Inc. (MCHX) Financial Ratios

Latest Ratios: P/E Ratio -16.3x · EV/EBITDA N/A · ROE -16.7%. (2002–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

MCHX Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$79M$81M$76M$58M$69M$109M$91M$172M$126M$154M$124M
Enterprise Value$70M$71M$64M$45M$50M$85M$67M$137M$81M$50M$20M
P/E Ratio →-16.27——————————
P/S Ratio1.751.771.571.161.332.041.773.151.481.710.96
P/B Ratio2.892.682.311.621.572.111.721.721.321.711.10
P/FCF———————50.3844.591341.69—
P/OCF———————33.7324.9291.19—

P/E links to full P/E history page with 30-year chart

MCHX EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—1.571.330.910.961.591.312.520.950.550.16
EV / EBITDA———————————
EV / EBIT———————————
EV / FCF———————40.2428.57435.69—

MCHX Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin63.2%63.2%64.3%58.8%60.8%59.4%59.2%67.0%43.9%45.4%40.6%
Operating Margin-9.6%-9.6%-9.2%-19.3%-15.6%-22.1%-86.0%-25.6%-4.6%-7.0%-64.8%
Net Profit Margin-11.5%-11.5%-10.3%-19.9%-15.8%-8.2%-75.1%-7.4%-3.1%-6.7%-64.9%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE-16.7%-16.7%-14.4%-24.8%-17.2%-8.4%-50.4%-4.1%-2.9%-6.0%-55.9%
ROA-12.6%-12.6%-10.9%-19.0%-13.4%-6.2%-38.2%-3.4%-2.3%-4.8%-50.5%
ROIC-15.6%-15.6%-15.0%-29.7%-23.1%-31.3%-70.2%-18.2%-16.4%—-143.6%
ROCE-13.3%-13.3%-12.4%-23.4%-16.7%-21.6%-54.1%-13.6%-4.1%-6.2%-55.6%

MCHX Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.020.020.040.060.040.060.190.07———
Debt / EBITDA———————————
Net Debt / Equity—-0.31-0.35-0.35-0.43-0.46-0.45-0.35-0.48-1.16-0.92
Net Debt / EBITDA———————————
Debt / FCF———————-10.13-16.02-906.00—
Interest Coverage——-37.06-32.87—-111.38-1463.50———-770.37

Net cash position: cash ($10M) exceeds total debt ($721000)

MCHX Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio2.362.362.402.452.562.962.023.564.293.708.37
Quick Ratio2.362.362.402.452.562.962.023.564.293.708.37
Cash Ratio1.231.231.381.501.702.141.622.383.033.186.99
Asset Turnover—1.141.111.050.920.810.670.440.750.731.01
Inventory Turnover———————————
Days Sales Outstanding—53.6053.6454.0758.7454.7545.1250.4169.3560.0753.31

MCHX Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield————————17.4%——
Payout Ratio———————————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield———————————
FCF Yield———————2.0%2.2%0.1%—
Buyback Yield0.0%0.0%0.0%0.0%0.0%0.0%12.0%0.0%4.5%0.0%0.3%
Total Shareholder Yield0.0%0.0%0.0%0.0%0.0%0.0%12.0%0.0%21.9%0.0%0.3%
Shares Outstanding—$49M$43M$43M$43M$44M$46M$45M$48M$48M$47M

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetHealthy
Cash FlowBurning
Top Statement Risk

Persistent Revenue Erosion

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Distressed Valuation Reflects Growth Stagnation

Based on reported figures, MCHX trades at a price-to-sales multiple of 1.54, a valuation that appears to reflect the market's skepticism regarding the company's ability to return to growth as it navigates a difficult transition toward AI-driven conversational intelligence products within a shrinking revenue base.

The negative P/E of -14.36 underscores the lack of current earnings power, suggesting that investors are currently assigning value primarily to the company's cash-rich balance sheet rather than its operational prospects. This valuation level warrants caution, as it implies the market may be pricing the firm as a terminal asset rather than a growth-oriented technology provider.

Capital Efficiency Decaying Amidst Losses

According to recent quarterly data, MCHX's ROIC has remained consistently negative, reaching -4.9% in 2026Q1, which indicates that the company is currently failing to generate returns on invested capital that exceed its cost of capital, thereby eroding shareholder value over the observed period.

The persistent negative ROIC trend suggests that the capital allocated toward R&D and product development has not yet translated into a scalable competitive advantage. Investors should monitor whether the company can achieve a positive return profile as it attempts to pivot its business model, as current trends suggest a structural inability to compound capital effectively.

Working Capital Efficiency Remains Stagnant

As reported in financial statements, the asset turnover ratio has hovered near 0.27 over the last ten quarters, indicating that the company's ability to generate revenue from its asset base remains limited and has not improved despite the strategic shift toward higher-margin software and AI-driven solutions.

The stability of the DSO around 57-60 days suggests that while the company maintains a consistent collection cycle, it lacks the pricing power or operational leverage to accelerate cash conversion. This lack of improvement in asset turnover highlights the difficulty of scaling a business model that remains heavily reliant on legacy telephony-based revenue streams.

Liquidity Buffer Masks Operational Fragility

Based on recent SEC filings, MCHX maintains a current ratio of 2.22 as of 2026Q1, which provides a comfortable liquidity cushion that effectively insulates the company from immediate insolvency risks despite the ongoing cash burn associated with its current negative operating margin profile.

While the quick ratio of 2.22 confirms that the company's liquidity is not overly dependent on inventory, the reliance on cash reserves to fund operations is not a sustainable long-term strategy. The current liquidity position appears adequate for the near term, but it does not mitigate the fundamental risk posed by the company's inability to achieve self-sustaining cash flow.

Misapplication of P/S Multiples

The price-to-sales ratio is frequently misapplied to MCHX, as it obscures the underlying shift in revenue quality from legacy call tracking to newer AI-driven intelligence products, potentially leading analysts to undervalue the potential of the company's proprietary conversational datasets in a broader AI-centric market.

Investors should instead focus on metrics like Net Revenue Retention (NRR) and AI automation rates, which provide a clearer picture of the company's operational health and future growth potential. Relying solely on P/S multiples ignores the structural transition the company is undergoing and fails to account for the latent value of its specialized industry data.

Download Financial Ratios Data

Includes 30+ ratios · 24 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

MCHX — Frequently Asked Questions

Quick answers to the most common questions about buying MCHX stock.

What is Marchex, Inc.'s P/E ratio?

Marchex, Inc.'s current P/E ratio is -16.3x. The historical average is 85.7x.

What is Marchex, Inc.'s ROE?

Marchex, Inc.'s return on equity (ROE) is -16.7%. The historical average is -20.9%.

Is MCHX stock overvalued?

Based on historical data, Marchex, Inc. is trading at a P/E of -16.3x. Compare with industry peers and growth rates for a complete picture.

What are Marchex, Inc.'s profit margins?

Marchex, Inc. has 63.2% gross margin and -9.6% operating margin.